patienthammer

54 results found.

Top Stocks matching your search for "patient hammer"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
NVOS

Novo Integrated Sciences Inc

6.11%

$0.13 - $0.14

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

The easing of COVID-19 restrictions enabled Novo’s... See more

Mar, 21, 2023

The easing of COVID-19 restrictions enabled Novo’s... See more

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0602/0802/1002/1402/1602/2102/2302/2703/0103/0303/0703/10
KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 24, 2023

"This long term study reinforces the efficacy... See more

Feb, 18, 2023

I recall an earlier posting last year of the same ... See more

JSPR

Jasper Therapeutics Inc

3.78%

$1.85 - $1.92

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

NVOS

Novo Integrated Sciences Inc

6.11%

$0.13 - $0.14

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 21, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 21, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 21, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 20, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 20, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 17, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 17, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 16, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 16, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

Mar, 16, 2023

The easing of COVID-19 restrictions enabled Novo’s practitioners to provide patients with additional in-person services.

KMPH

KemPharm Inc

-26.64%

$5.63 - $4.13

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 24, 2023

"This long term study reinforces the efficacy and safety of AZSTARYS as an important treatment option for healthcare professionals to consider when choosing the optimal ADHD therapy for their patients."

Feb, 18, 2023

I recall an earlier posting last year of the same clinic who said patients were doing well and parents were liking the appetite benefits

Jan, 23, 2023

$KMPH On the Facebook adhd forums, a mom said her sons doctor has had a few patients on azstarys and has had no complaints.

Jan, 20, 2023

$KMPH 700 new patients last week I'll take that!

Jan, 20, 2023

but again given the seasonality of ADHD in early school season combined with the Holidays, imo pretty OK. Actually gained more net new patients then Qelbree. .

Jan, 3, 2023

However, what I like best is that it is working on actual patients.

Dec, 30, 2022

Shows a strong base of patients.

Dec, 25, 2022

Here's to a great 2023 with scripts continuing increasing by 500 plus patients per week, great IH results and submitting to the fda our arimiclomol application

Dec, 19, 2022

And they are sooo patient

Dec, 19, 2022

So I am very positive this is a good treatment for me.